-
Mashup Score: 0OpenAI goes for Microsoft’s jugular — its Office productivity suite - 9 minute(s) ago
The ChatGPT maker is eyeing the launch of its own productivity suite with generative AI built in, directly attacking Microsoft’s multibillion dollar Microsoft 365 office suite business.
Source: www.computerworld.comCategories: General Medicine NewsTweet
-
Mashup Score: 0
In 2004, Hsu and colleagues reported persistent left superior vena cava (PLSVC) as a potential source of atrial fibrillation (AF) triggers.1 Pulsed field ablation (PFA) is a non-thermal modality primarily developed to treat AF through pulmonary vein isolation.2 As the first commercial case was in 2021, there is limited experience on the use of PFA for potential non-pulmonary vein sources.2 In addition, the effect of direct contact between PFA and indwelling cardiac implantable electronic device (CIED) leads is largely unknown.
Source: www.heartrhythmcasereports.comCategories: General Medicine NewsTweet
-
Mashup Score: 0Surgeons’ Contributions to Antibiotic Stewardship and Resistance Prevention - 24 minute(s) ago
This survey study evaluates how surgeons in France understand their role in preventing antibiotic resistance.
Source: jamanetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 0Imaging and pulmonary function techniques in ARDS diagnosis and management: current insights and challenges - Critical Care - 39 minute(s) ago
Acute Respiratory Distress Syndrome (ARDS) is a life-threatening condition characterized by acute onset of respiratory failure, which presents significant challenges in diagnosis and management. Its heterogeneity, with diverse underlying aetiologies and variable patient responses to treatment, highlights the need for individualized care approaches. Accurate and timely diagnosis, coupled with personalized therapy, is essential to improving patient outcomes. In this context, the integration of advanced lung imaging techniques, such as chest computed tomography, lung ultrasound, and electrical impedance tomography, with functional parameters (like respiratory system compliance, driving pressure, transpulmonary pressure, and mechanical power) has emerged as a promising approach to enhance diagnostic precision. These imaging modalities provide valuable insights into the patient’s underlying respiratory mechanics and enable better assessment of disease severity. However, the clinical applica
Source: ccforum.biomedcentral.comCategories: General Medicine NewsTweet
-
Mashup Score: 2
In the Nature Index 2025 Research Leaders list released in June, the Mount Sinai Health System earned top marks: among health care institutions in the United States and North America, it was No. 5 for its research output. When compared against health care institutions around the world, Mount Sinai ranked sixth.
Source: health.mountsinai.orgCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 0Breaking Down What CAR T-Cell Therapy Means for Blood Cancers - 44 minute(s) ago
Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of outpatient CAR T-cell therapy treatment.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0
Background Patients with diabetes mellitus (DM) have an elevated risk of late events after percutaneous coronary intervention (PCI). The Second-generation Drug-eluting Stents in Diabetes (SUGAR) trial ([NCT03321032][1]) compared amphilimus-eluting stents (AESs) and onyx-zotarolimus-eluting stents (O-ZESs) in this population. Objectives To report the co-primary endpoint comparing target lesion failure (TLF) between AES and O-ZES at 2 years and the extended follow-up at 3 years. Methods The SUGAR trial enrolled 1175 patients with DM across 23 centres in a randomised (1:1 AES (Cre8EVO) or O-ZES (Resolute Onyx)) assessor-blinded design. The primary endpoint, assessed with a Cox proportional hazards model, was TLF (a composite of cardiac death, target vessel myocardial infarction or ischaemia-driven target lesion revascularisation). Secondary endpoints included all-cause mortality, stent thrombosis and major adverse cardiac events. Results At 2 years, TLF occurred in 60 (10.4%) patients in
Source: heart.bmj.comCategories: General Medicine NewsTweet
-
Mashup Score: 0AstraZeneca Blockbuster Prospect Is a Bust in Pivotal Test in Light Chain Amyloidosis - MedCity News - 51 minute(s) ago
Though anselamimab failed its Phase 3 test in light chain amyloidosis, AstraZeneca points to encouraging results in a pre-defined patient subgroup — which may not be a winning strategy. Prothena resurrected its failed drug candidate for the disease based on a subgroup analysis, only to see that antibody fall short in a pivotal study.
Source: medcitynews.comCategories: General Medicine NewsTweet
-
Mashup Score: 0ISHLT2026 Call for Abstract Reviewers - 55 minute(s) ago
As ISHLT prepares for another exciting year of innovative research, interested members are invited to apply to serve as Abstract Reviewers for ISHLT2026. Complete the online application by Thursday, 31 July at 11:59 p.m. ET / Friday, 1 August at 3:59 UTC.
Source: www.ishlt.orgCategories: General Medicine NewsTweet
-
Mashup Score: 0
Proximie and Imperative Care today announced a partnership aimed at driving the development of a surgical robot to treat ischemic stroke.
Source: www.massdevice.comCategories: General Medicine NewsTweet
The ChatGPT maker is eyeing the launch of its own productivity suite with generative AI built in, directly attacking Microsoft’s multibillion dollar Microsoft 365 office suite business Source: Computerworld https://t.co/xIiBgri6Xr